Authors
Latest:
Juvenile Diabetes Rates IncreasePediatric diabetes and pediatric diabetic nephropathy rates significantly increase at age 12.
Latest:
Rehospitalizations and Direct Medical Costs for cSSSI: Linezolid Versus VancomycinAmong commercially insured patients treated with linezolid or vancomycin following cSSSI-related hospitalization, linezolid was associated with significantly lower rehospitalization rates and total direct medical costs.
Latest:
Exploring the Versatility of Azelaic Acid in Facial Acne, Truncal Acne, Photoaging, and MelasmaContinuing education activity featured in the March 2018 edition of Pharmacy Times.
Latest:
Opportunities for Collaboration in Clinical Pharmacy ServicesAs the relationship between pharmacist and physician developed, doctors began asking the pharmacist to go beyond offering advice and to initiate changes to the drug and dosage regimens in response to patients' signs and symptoms.
Latest:
The Impact of Abuse Deterrent Technologies on Prescription Opioid TrendsThe authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.
Latest:
Pharmacists Are Key to Addressing Flu Vaccine HesitancyA strong recommendation from trusted health care professionals can make a difference.
Latest:
Exploring Nursing Adherence Programs for Oral OncolyticsSpecialty pharmacies are becoming more involved in programs that focus on the management of oral oncolytics. The role of health care workers, including pharmacists, physicians, and nurses, is being defined as this therapeutic class grows.
Latest:
A Call to Action for Evidence-based, Outcomes-driven Conflict Management StylesWith expanding pharmacy practice, it is time to explore conflict management, and its necessity in this current climate.
Latest:
Pilot Pharmacoeconomic Analysis of Serum-derived Bovine Immunoglobulin Use in IBDThis pilot study analyzes the cost savings of utilizing a prescription medical food, serum-derived bovine immunoglobulin/protein isolate, for the management of inflammatory bowel disease in a small cohort.
Latest:
Patient Preference for Treatment Administration in Cystic FibrosisThis study assesses the preferences of patients with cystic fibrosis for treatments that differ in the mode of administration.
Latest:
Consider Impact of Certain Medications on Brain FunctionPharmacists can identify drugs that cause problems, guide selection, and recommend treatment strategies.
Latest:
Cannabidiol Products' Impact on Pharmacist-Provided Medication ManagementPharmacists can assist with advising patients who present with quality concerns to use CBD products that provide certificates of analyses, and catch significant drug interactions before they occur.
Latest:
2014 Surprise: Unexpected Doubling of Out-of-Pocket MaximumThe Affordable Care Act will help people access quality healthcare by capping their out-of-pocket costs. But some patients will face a significantly higher cap.
Latest:
How the CDC’s COVID-19 Pharmacy Partnership for Long-Term Care Program Will Benefit 3 GroupsThroughout the pandemic, we have taken an aggressive approach to service and safety, ensuring that there would be no disruption in services, and even expanding our offerings during these difficult times to include virtual onboarding and contactless delivery.
Latest:
When Will a Vaccine Be Ready?As we head into flu season, count on Directions in Health-System Pharmacy™ to continue to report on the latest developments on COVID-19.
Latest:
Local Health Care Partnerships Are Strongly Associated With Successful Enhanced Community Pharmacy ServicesIncorporating community pharmacists into team-based care models is recommended as a strategy for improving health care access and quality while reducing health care costs.
Latest:
Atypical Antipsychotic-Induced Type 2 DiabetesPatients with schizophrenia and other disorders who take atypical antipsychotics should be monitored for an increased risk for diabetes.
Latest:
Trends in Statin Treatment Costs and Potential Impact of Novel TherapiesGeneric atorvastatin led to an increase in generic dispensing rate and a reduction in the cost of treatment for patients requiring cholesterol-lowering treatment. The upcoming introduction of the PCSK9 inhibitor may change this trend.
Latest:
2010 Next-Generation Pharmacist and Entrepreneur of the Year: Mark AuritIn 2010, Mark Aurit won the Entrepreneur of the Year category and went on to be named the inaugural Next-Generation Pharmacist.
Latest:
Glycemic Control and CVD: Making Sense of the StudiesPatients with diabetes have a 2- to 4-fold higher risk of stroke and death from heart disease; the counseling implications are discussed here.
Latest:
Synergies Identified Between Health Systems and Home Infusion PharmaciesPartnerships are key between home infusion and hospitals to alleviate costs on the health system.
Latest:
Some of Health Care's Biggest Names Also Top HIPAA Violators, Investigation FindsThe public interest journalism group ProPublica examined records from 2011 through 2014 and found that not only are HIPAA violations common, but they also typically go unpunished.
Latest:
Specialty Pharmacists Play a Vital Part in the Treatment of Hepatitis CPharmacists provide medication expertise that is essential to both the patient and the health care team in the treatment of hepatitis C.
Latest:
Malignant Melanoma: The Implications of Cost for Stakeholder InnovationAn activity-based cost accounting model of melanoma care was used to identify key cost drivers and opportunities for stakeholder innovation.
Latest:
Generational Impact on Prescription Drug Trend: Part 2This retrospective study of 558.9 million prescription claims explores how member age demographics affect prescription drug trends and provides top therapeutic classes by generation.
